<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Our early experience with Selectron <z:chebi fb="14" ids="53218">MDR</z:chebi> in treating <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e> patients at Osaka University Hospital is presented </plain></SENT>
<SENT sid="1" pm="."><plain>From May 1991 through December 1992, a total of 22 patients (stage Ia, 1; stage Ib, 3; stage IIa, 1; stage IIb, 2; stage IIIb, 13 and stage IVa, 2) with previously untreated <z:e sem="disease" ids="C0007847" disease_type="Neoplastic Process" abbrv="">uterine cervical cancer</z:e> and intact uterus were treated with mid-dose rate intracavitary therapy administered with a Selectron </plain></SENT>
<SENT sid="2" pm="."><plain>A rigid applicator made of stainless steel for the Selectron was used for the treatment </plain></SENT>
<SENT sid="3" pm="."><plain>The 137Cs source had an activity of 1.48 GBq as of reference time </plain></SENT>
<SENT sid="4" pm="."><plain>Source loading corresponded to the Manchester System </plain></SENT>
<SENT sid="5" pm="."><plain>Early <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> responses for <z:hpo ids='HP_0000001'>all</z:hpo> patients were complete </plain></SENT>
<SENT sid="6" pm="."><plain>No <z:hpo ids='HP_0011009'>acute</z:hpo> radiation injury has been observed </plain></SENT>
<SENT sid="7" pm="."><plain>There have been two local recurrences in stage IIIb patients </plain></SENT>
<SENT sid="8" pm="."><plain>One of them developed para-aortic lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and died from distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Another patient in stage IIIb had para-aortic and left supraclavicular lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and died from distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Four patients developed <z:hpo ids='HP_0002573'>rectal bleeding</z:hpo> (grade 1, 3; grade 3, 1) </plain></SENT>
<SENT sid="11" pm="."><plain>One of them had been treated for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> with steroid </plain></SENT>
<SENT sid="12" pm="."><plain>The cause of grade 3 <z:hpo ids='HP_0002573'>rectal bleeding</z:hpo> was considered to be technical failure in intracavitary application </plain></SENT>
<SENT sid="13" pm="."><plain>The remaining two patients recovered without treatment </plain></SENT>
<SENT sid="14" pm="."><plain>From our early experience, it is concluded that Selectron <z:chebi fb="14" ids="53218">MDR</z:chebi> can be used for <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e> patients as safely and effectively as our previously used high-dose rate machine </plain></SENT>
</text></document>